Barclays raised the firm’s price target on Catalent to $55 from $42 and keeps an Equal Weight rating on the shares. The analyst views the company’s sales guidance as “aggressive” and finds the stock fully valued unless SRP9001 and GLP-1s drive significant upside.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CTLT: